Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Healthsouth Corp (HLS)

Healthsouth Corp (HLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Healthsouth Corp 3660 GRANDVIEW PARKWAY SUITE 200 BIRMINGHAM AL 35243 USA

www.healthsouth.com P: 205-967-7116

Description:

HealthSouth Corporation is dedicated to comprehensive rehabilitation medicine. In the hospital and at home, HealthSouth's team of experts is focused solely on rehabilitation. They collaborate closely on decisions, goals and therapy options. Their priority is to deliver high quality patient care and their team of experts has extensive experience in today's most advanced therapeutic methods and technologies. HealthSouth leads the way, intensive approach to rehabilitation, returning patients to full strength in less than average time. HealthSouth has the most advanced technology, a highly qualified rehabilitation team and unparalleled depth of experience. Therapy is performed to get the patient back to the highest level of strength and function after illness, injury or surgery. The focus is completely on the patient and family, doing what's right for recovery in a positive atmosphere of encouragement, support and respect for individual needs.

Key Statistics

Overview:

Market Capitalization, $K 4,857,497
Shares Outstanding, K 98,310
Annual Sales, $ 3,646 M
Annual Net Income, $ 247,600 K
Last Quarter Sales, $ 983,000 K
Last Quarter Net Income, $ 65,900 K
60-Month Beta 0.54
% of Insider Shareholders 1.60%
% of Institutional Shareholders 93.18%

Growth:

1-Year Return 18.92%
3-Year Return 32.61%
5-Year Return 123.78%
5-Year Revenue Growth 79.88%
5-Year Earnings Growth 57.99%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.66 on 10/26/17
Latest Earnings Date 02/20/18
Earnings Per Share ttm 2.79
EPS Growth vs. Prev Qtr -7.04%
EPS Growth vs. Prev Year 1.54%
Annual Dividend Rate, $ 1.00
Annual Dividend Yield 2.02%
Most Recent Dividend 0.250 on 09/29/17
Next Ex-Dividends Date 12/29/17
Dividend Payable Date 01/16/18
Dividend Payout Ratio 33.99%
Most Recent Split 1-5 on 10/26/06

HLS Ratios

Ratio
Price/Earnings ttm 17.76
Price/Earnings forward 17.00
Price/Earnings to Growth 1.70
Return-on-Equity % 22.81%
Return-on-Assets % 5.49%
Profit Margin % 6.79%
Debt/Equity 3.21
Price/Sales 1.31
Price/Cash Flow 10.04
Price/Book 3.55
Book Value/Share 13.91
Interest Coverage 4.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar